SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: Mudcat who wrote (19972)5/3/1998 9:30:00 PM
From: John O'Neill  Read Replies (2) | Respond to of 32384
 
The "Spin doctors vs the nea sayers is interesting" but I'm most interested in whether LGND will break out of $18 range on upcoming pipeline, or just wallow in the $12-$15 range. Is anyone else primarily concerned
about this?? ( I own the stock)..or am I one of the Lone Rangers here? " . Any opinions?

JO



To: Mudcat who wrote (19972)5/3/1998 9:37:00 PM
From: squetch  Read Replies (2) | Respond to of 32384
 
I don't read the Yahoo board. Can someone tell me if that is dnarna's only post?



To: Mudcat who wrote (19972)5/3/1998 9:48:00 PM
From: Dan O.  Read Replies (1) | Respond to of 32384
 
Mudcat, The guy said "The key, as always, is to separate facts from opinion". The only fact that he offered was Glaxo's investment (which I don't know is true but will accept at face value). Everything else was his opinion.

Doesn't anyone see the irony in this?

And for what it's worth some of us have stated we agreed with his opinions!

Of course he doesn't have a legal staff to review it word for word. He'd only need one if he wrote it on his company stationary, but...

What he (and many of use) need are editors.

And a Glenlivet on the rocks, <g>, g'night.

Dan Ogens